Table 2.

Relationship of 6MWT to disease severity and other measures of mobility

	6MWT
Measure	UR (ρ; P value)	KKI (ρ; P value)	Combined Sites (ρ; P value)
FSHD Clinical Score	−0.74; <0.0001	−0.42; 0.009*	−0.57; <0.0001
TUG	−0.89; <0.0001	−0.73; <0.0001ǂ	−0.81; <0.0001
30 foot GO/10MT	−0.88; <0.0001	−0.78; <0.0001†	−0.83; <0.0001

^*FSHD Clinical Score available for 38 of 51 subjects

^†10 MT available for 50 of 51 subjects

^ǂTUG available for 48 of 51 subjects